Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-15 Sale | 2024-11-19 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 15 | $478.56 | $7,178 | 25,813 (Direct) | View |
| 2024-11-11 Sale | 2024-11-13 4:15 pm | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 3,000 | $518.27 | $1,554,810 | 44,137 (Direct) | View |
| 2024-11-08 Sale | 2024-11-12 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 15,198 | $515 | $7,826,970 | 75,772 (Direct) | View |
| 2024-10-02 Sale | 2024-10-03 4:12 pm | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 999 | $461.66 | $461,198 | 16,651 (Direct) | View |
| 2024-08-30 Sale | 2024-09-04 4:13 pm | VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman | 3,784 | $499 | $1,888,216 | 10,434 (Indirect Direct) | View |
| 2024-08-30 Sale | 2024-09-04 4:12 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director | 646 | $500 | $323,000 | 4,435 (Direct) | View |
| 2024-08-08 Sale | 2024-08-12 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director | 1,292 | $466.29 | $602,447 | 5,081 (Direct) | View |
| 2024-08-07 Sale | 2024-08-08 4:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 2,280 | $476.75 | $1,086,990 | 23,259 (Direct) | View |
| 2024-08-01 Sale | 2024-08-02 4:10 pm | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 5,295 | $508 | $2,689,860 | 40,000 (Direct) | View |
| 2024-07-30 Sale | 2024-08-01 4:17 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 15,202 | $505 | $7,677,010 | 90,970 (Direct) | View |
| 2024-07-24 Sale | 2024-07-25 4:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 2,280 | $488.46 | $1,113,689 | 25,539 (Direct) | View |
| 2024-07-22 Sale | 2024-07-24 4:05 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 15,202 | $497 | $7,555,394 | 106,172 (Direct) | View |
| 2024-07-10 Sale | 2024-07-12 4:07 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 2,280 | $487.34 | $1,111,135 | 27,819 (Direct) | View |
| 2024-06-26 Sale | 2024-06-28 4:04 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 2,280 | $471.72 | $1,075,522 | 30,099 (Direct) | View |
| 2024-06-12 Sale | 2024-06-13 4:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 2,280 | $478 | $1,089,840 | 32,379 (Direct) | View |
| 2024-06-12 Sale | 2024-06-13 4:09 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 7,288 | $478 | $3,483,664 | 15,972 (Direct) | View |
| 2024-06-03 Sale | 2024-06-05 4:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 3,250 | $460 | $1,495,000 | 47,137 (Direct) | View |
| 2024-06-03 Sale | 2024-06-05 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,175 | $460 | $1,000,500 | 49,098 (Direct) | View |
| 2024-05-30 Sale | 2024-06-03 4:09 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 4,600 | $441.99 | $2,033,159 | 51,273 (Direct) | View |
| 2024-05-29 Sale | 2024-05-31 4:19 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 2,280 | $445.56 | $1,015,877 | 34,659 (Direct) | View |
| 2024-05-28 Sale | 2024-05-30 4:07 pm | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 3,250 | $454.79 | $1,478,068 | 50,387 (Direct) | View |
| 2024-05-24 Sale | 2024-05-29 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 1,565 | $457 | $715,205 | 121,374 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:13 pm | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 7,073 | $448 | $3,168,704 | 40,000 (Direct) | View |
| 2024-05-20 Sale | 2024-05-22 4:21 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 15,202 | $447 | $6,795,294 | 121,374 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 4:27 pm | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 32 | $430.93 | $13,790 | 62,772 (Indirect Direct) | View |
| 2024-05-15 Sale | 2024-05-17 4:24 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 69 | $430.93 | $29,734 | 49,831 (Indirect Direct) | View |
| 2024-05-15 Sale | 2024-05-17 4:22 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 54 | $430.93 | $23,270 | 25,813 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-15 Option Award | 2024-10-17 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 90 | $484.39 | 15,033 (Direct) | View |
| 2024-10-01 Tax Withholding | 2024-10-03 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 630 | $466.84 | 16,651 (Direct) | View |
| 2024-08-30 Exercise | 2024-09-04 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director | 646 | $152.74 | 4,435 (Direct) | View |
| 2024-08-30 Exercise | 2024-09-04 4:12 pm | N/A 2028-05-31 | VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director | 646 | $0 | 4,435 (Direct) | View |
| 2024-08-08 Exercise | 2024-08-12 4:08 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director | 1,292 | $152.74 | 5,081 (Direct) | View |
| 2024-08-08 Exercise | 2024-08-12 4:08 pm | N/A 2028-05-31 | VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director | 1,292 | $0 | 5,081 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-02 4:10 pm | N/A 2027-05-31 | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 5,295 | $0 | 40,000 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-02 4:10 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 5,295 | $125.71 | 40,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:13 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 89 | $490.12 | 14,943 (Direct) | View |
| 2024-06-11 Tax Withholding | 2024-06-13 4:09 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 6,824 | $481.96 | 15,972 (Direct) | View |
| 2024-06-05 Gift | 2024-06-07 4:07 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 4,600 | $0 | 58,172 (Indirect) | View |
| 2024-05-24 Exercise | 2024-05-29 4:08 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 1,565 | $0 | 121,374 (Direct) | View |
| 2024-05-24 Exercise | 2024-05-29 4:08 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 1,565 | $187.53 | 121,374 (Direct) | View |
| 2024-05-22 Exercise | 2024-05-24 4:13 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 7,073 | $93.51 | 40,000 (Direct) | View |
| 2024-05-22 Exercise | 2024-05-24 4:13 pm | N/A 2026-05-31 | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 7,073 | $0 | 40,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 4:18 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Schneider Jennifer Director | 922 | $0 | 922 (Direct) | View |
| 2024-05-14 Option Award | 2024-05-16 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 14,112 | $0 | 30,084 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:26 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director | 2,169 | $0 | 3,962 (Direct) | View |
| 2024-05-01 Disposition | 2024-05-03 4:26 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director | 1,168 | $0 | 3,962 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:23 pm | N/A 2034-04-30 | VERTEX PHARMACEUTICALS INC | VRTX | Thornberry Nancy Director | 2,072 | $0 | 3,208 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:21 pm | N/A 2034-04-30 | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 3,142 | $0 | 3,142 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:18 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director | 2,169 | $0 | 8,633 (Direct) | View |
| 2024-05-01 Disposition | 2024-05-03 4:18 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director | 1,168 | $0 | 8,633 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:16 pm | N/A 2034-04-30 | VERTEX PHARMACEUTICALS INC | VRTX | Lagarde Michel Director | 3,142 | $0 | 3,142 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:14 pm | N/A 2034-04-30 | VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director | 3,142 | $0 | 3,142 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:11 pm | N/A 2034-04-30 | VERTEX PHARMACEUTICALS INC | VRTX | Garber Alan M Director | 3,142 | $0 | 3,142 (Direct) | View |